Trimethoprim-sulfamethoxazole Versus Azithromycin for the Treatment of Undifferentiated Febrile Illness in Nepal: A Double-blind, Randomized, Placebo-controlled Trial

BACKGROUND: Azithromycin and trimethoprim-sulfamethoxazole (SXT) are widely used to treat undifferentiated febrile illness (UFI). We hypothesized that azithromycin is superior to SXT for UFI treatment, but the drugs are noninferior to each other for culture-confirmed enteric fever treatment. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Giri, Abhishek, Karkey, Abhilasha, Dangol, Sabina, Arjyal, Amit, Pokharel, Sunil, Rijal, Samita, Gajurel, Damodar, Sharma, Rabi, Lamsal, Kamal, Shrestha, Pradip, Prajapati, Gayatri, Pathak, Saruna, Shrestha, Sita Ram, K.C, Raj Kumar, Pandey, Sujata, Thapa, Abishkar, Shrestha, Nistha, Thapa, Raj Kumar, Poudyal, Buddhi, Phuong, Dung Nguyen Thi, Baker, Stephen, Kestelyn, Evelyne, Geskus, Ronald, Thwaites, Guy, Basnyat, Buddha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492158/
https://www.ncbi.nlm.nih.gov/pubmed/32991678
http://dx.doi.org/10.1093/cid/ciaa1489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492158/
https://www.ncbi.nlm.nih.gov/pubmed/32991678
http://dx.doi.org/10.1093/cid/ciaa1489

Ejemplares similares